Novartis AG beats Q2 2025 expectations, but patent expiries and policy risks loom. Click for my updated look at NVS earnings ...

S$0.025 loss per share (improved from S$0.031 loss in FY 2024). AI is about to change healthcare. These 20 stocks are working ...

Key Points - GAAP earnings per share and revenue for Q2 2025 missed analyst estimates. Net interest income and net interest margin (GAAP) improved significantly, boosted by investment portfolio ...

Loan growth, net of payoffs, reached 11% annualized in Q2 2025, supported by an active pipeline across commercial and ...

Investing.com -- RBB Bancorp (NASDAQ: RBB) reported second-quarter earnings that significantly exceeded analyst expectations, driving shares up 4.5% as the company benefited from stronger loan growth ...

U.S. stocks moved higher on Monday as optimism around earnings overshadowed any investor fears over the latest developments ...

Analysts estimate that Cathay General will report an earnings per share (EPS) of $1.10. The market awaits Cathay General's ...

Analysts are estimating that Usana Health Sciences will report an earnings per share (EPS) of $0.54. The market awaits Usana Health Sciences's announcement, with hopes high for news of surpassing ...

Corporate results for the second quarter will be “critical to the longevity” of the bounce of small-cap and mid-cap stocks, ...

The second quarter was a challenging one for the stock market—and a winner for Charles Schwab. The wealth management company ...

Wall Street analysts predict lower second-quarter profits for Ford, GM and Stellantis due to tariff pressures and slowing sales.

Roper Technologies’ ROP second-quarter 2025 adjusted earnings of $4.87 per share surpassed the Zacks Consensus Estimate of $4 ...